Epigenetic flexibility in metabolic regulation: Disease cause and prevention?

Trends in Cell Biology

Volumn 23, Issue 5, 2013, Pages 203-209

  Kirchner, Henriette ^a   Osler, Megan E ^a   Krook, Anna ^a   Zierath, Juleen R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

DNA methylation; Exercise; Metabolic programming; Nutrition; Type 2 diabetes

Indexed keywords

HISTONE;

DNA METHYLATION; EPIGENETICS; GENOME; HISTONE MODIFICATION; HUMAN; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

DIABETES MELLITUS, TYPE 2; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; EXERCISE; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; LIFE STYLE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; PREGNANCY;

EID: 84876784115     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.11.008     Document Type: Review

References (66)

1. Baylin S.B., Jones P.A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 2011, 11:726-734.
2. Pinney S.E., et al. Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 2011, 54:2606-2614.
3. Epigenetic Mechanisms of Gene Regulation 1996, Cold Spring Harbor Laboratory Press. A.D.R. Riggs (Ed.).
4. Feil R., Fraga M.F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 2011, 13:97-109.
5. Qureshi I.A., Mehler M.F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 2012, 13:528-541.
6. Barres R., et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012, 15:405-411.
7. McGee S.L., et al. Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle. FASEB J. 2006, 20:348-349.
8. Holliday R., Pugh J.E. DNA modification mechanisms and gene activity during development. Science 1975, 187:226-232.
9. Riggs A.D. X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 1975, 14:9-25.
10. Lister R., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
11. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9:465-476.
12. Barres R., et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009, 10:189-198.
13. Yan J., et al. Evidence for non-CpG methylation in mammals. Exp. Cell Res. 2011, 317:2555-2561.
14. Li E., et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
15. Okano M., et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
16. Chen W.Y., et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet. 2003, 33:197-202.
17. Suzuki H., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 2004, 36:417-422.
18. Nguyen C.T., et al. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 2001, 29:4598-4606.
19. Rideout W.M., et al. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990, 249:1288-1290.
20. He Y.F., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
21. Ito S., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
22. Nelson V.R., Nadeau J.H. Transgenerational genetic effects. Epigenomics 2010, 2:797-806.
23. Sasaki H., Matsui Y. Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat. Rev. Genet. 2008, 9:129-140.
24. Surani M.A., et al. Genetic and epigenetic regulators of pluripotency. Cell 2007, 128:747-762.
25. Lucas A. Role of nutritional programming in determining adult morbidity. Arch. Dis. Child. 1994, 71:288-290.
26. Li B., et al. The role of chromatin during transcription. Cell 2007, 128:707-719.
27. Koch C.M., et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 2007, 17:691-707.
28. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
29. Wang Z., et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009, 138:1019-1031.
30. Keogh M.C., et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 2005, 123:593-605.
31. Yu M., et al. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. J. Physiol. 2001, 536:273-282.
32. Ravelli G.P., et al. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 1976, 295:349-353.
33. Seki Y., et al. Minireview: epigenetic programming of diabetes and obesity: animal models. Endocrinology 2012, 153:1031-1038.
34. Carone B.R., et al. Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 2010, 143:1084-1096.
35. Ng S.F., et al. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010, 467:963-966.
36. Park J.H., et al. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 2008, 118:2316-2324.
37. Simmons R.A., et al. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001, 50:2279-2286.
38. Gluckman P.D., Hanson M.A. Maternal constraint of fetal growth and its consequences. Semin. Fetal Neonatal Med. 2004, 9:419-425.
39. Kaati G., et al. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur. J. Hum. Genet. 2002, 10:682-688.
40. Vadlamudi S., et al. Persistence of metabolic consequences in the progeny of rats fed a HC formula in their early postnatal life. Am. J. Physiol. 1995, 269:E731-E738.
41. Odom D.T., et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303:1378-1381.
42. Sandovici I., et al. Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5449-5454.
43. Gupta R.K., et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev. 2007, 21:756-769.
44. Silander K., et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 2004, 53:1141-1149.
45. Brissova M., et al. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E707-E714.
46. Kulkarni R.N., et al. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Invest. 2004, 114:828-836.
47. Ollikainen M., et al. DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum. Mol. Genet. 2010, 19:4176-4188.
48. Volkmar M., et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012, 31:1405-1426.
49. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10604-10609.
50. Kaminsky Z.A., et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet. 2009, 41:240-245.
51. Nitert M.D., et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 2012, 61:3322-3332.
52. Mack G.S. Epigenetic cancer therapy makes headway. J. Natl. Cancer Inst. 2006, 98:1443-1444.
53. Ronn T., et al. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 2008, 51:1159-1168.
54. Eriksson K.F., Lindgarde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 1996, 39:573-579.
55. Miles J.L., et al. Moderate daily exercise activates metabolic flexibility to prevent prenatally induced obesity. Endocrinology 2009, 150:179-186.
56. Phelan S., et al. Maternal behaviors during pregnancy impact offspring obesity risk. Exp. Diabetes Res. 2011, 2011:985139.
57. McKinsey T.A., et al. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 2001, 11:497-504.
58. Lu J., et al. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 2000, 6:233-244.
59. Czubryt M.P., et al. Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1711-1716.
60. Potthoff M.J., et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 2007, 117:2459-2467.
61. Tateishi K., et al. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 2009, 458:757-761.
62. McGee S.L., Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin. Exp. Pharmacol. Physiol. 2006, 33:395-399.
63. McGee S.L., Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 2004, 53:1208-1214.
64. Kuehnen P., et al. An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet. 2012, 8:e1002543.
65. Ling C., et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008, 51:615-622.
66. Ling C., et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest. 2007, 117:3427-3435.